|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chua ML, Wee JT, Hui EP and Chan AT:
Nasopharyngeal carcinoma. Lancet. 387:1012–1024. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blanchard P, Lee A, Marguet S, Leclercq J,
Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, et al:
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: An
update of the MAC-NPC meta-analysis. Lancet Oncol. 16:645–655.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ulvmar MH, Hub E and Rot A: Atypical
chemokine receptors. Exp Cell Res. 317:556–568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Massara M, Bonavita O, Mantovani A, Locati
M and Bonecchi R: Atypical chemokine receptors in cancer: Friends
or foes? J Leukoc Biol. 99:927–933. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feng LY, Ou ZL, Wu FY, Shen ZZ and Shao
ZM: Involvement of a novel chemokine decoy receptor CCX-CKR in
breast cancer growth, metastasis and patient survival. Clin Cancer
Res. 15:2962–2970. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harata-Lee Y, Turvey ME, Brazzatti JA,
Gregor CE, Brown MP, Smyth MJ, Comerford I and McColl SR: The
atypical chemokine receptor CCX-CKR regulates metastasis of mammary
carcinoma via an effect on EMT. Immunol Cell Biol. 92:815–824.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hou T, Liang D, Xu L, Huang X, Huang Y and
Zhang Y: Atypical chemokine receptors predict lymph node metastasis
and prognosis in patients with cervical squamous cell cancer.
Gynecol Oncol. 130:181–187. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu Y, Tang W, Liu Y, Wang G, Liang Z and
Cui L: CCX-CKR expression in colorectal cancer and patient
survival. Int J Biol Markers. 29:e40–e48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hernandez-Gea V, Toffanin S, Friedman SL
and Llovet JM: Role of the microenvironment in the pathogenesis and
treatment of hepatocellular carcinoma. Gastroenterology.
144:512–527. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pang MF, Georgoudaki AM, Lambut L,
Johansson J, Tabor V, Hagikura K, Jin Y, Jansson M, Alexander JS,
Nelson CM, et al: TGF-β1-induced EMT promotes targeted migration of
breast cancer cells through the lymphatic system by the activation
of CCR7/CCL21-mediated chemotaxis. Oncogene. 35:748–760. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mo M, Zhou M, Wang L, Qi L, Zhou K, Liu
LF, Chen Z and Zu XB: CCL21/CCR7 enhances the proliferation,
migration, and invasion of human bladder cancer T24 cells. PLoS
One. 10:e01195062015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Elinav E, Nowarski R, Thaiss CA, Hu B, Jin
C and Flavell RA: Inflammation-induced cancer: Crosstalk between
tumours, immune cells and microorganisms. Nat Rev Cancer.
13:759–771. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Forster R, Schubel A, Breitfeld D, Kremmer
E, Renner-Muller I, Wolf E and Lipp M: CCR7 coordinates the primary
immune response by establishing functional microenvironments in
secondary lymphoid organs. Cell. 99:23–33. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi JY, Yang LX, Wang ZC, Wang LY, Zhou J,
Wang XY, Shi GM, Ding ZB, Ke AW, Dai Z, et al: CC chemokine
receptor-like 1 functions as a tumour suppressor by impairing
CCR7-related chemotaxis in hepatocellular carcinoma. J Pathol.
235:546–558. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiong Y, Huang F, Li X, Chen Z, Feng D,
Jiang H, Chen W and Zhang X: CCL21/CCR7 interaction promotes
cellular migration and invasion via modulation of the MEK/ERK1/2
signaling pathway and correlates with lymphatic metastatic spread
and poor prognosis in urinary bladder cancer. Int J Oncol.
51:75–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Irshad S, Flores-Borja F, Lawler K,
Monypenny J, Evans R, Male V, Gordon P, Cheung A, Gazinska P, Noor
F, et al: RORγt+ Innate lymphoid cells promote lymph node
metastasis of breast cancers. Cancer Res. 77:1083–1096. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma H, Gao L, Li S, Qin J, Chen L, Liu X,
Xu P, Wang F, Xiao H, Zhou S, et al: CCR7 enhances TGF-β1-induced
epithelial-mesenchymal transition and is associated with lymph node
metastasis and poor overall survival in gastric cancer. Oncotarget.
6:24348–24360. 2015. View Article : Google Scholar : PubMed/NCBI
|
